Ernexa Therapeutics Inc. Share Price
NASDAQ: ERNA | Micro Cap$4.40
+$4.40 (--%) Last updated on 04 Sep, 2026 | 22:39 ISTErnexa Therapeutics Inc. Stock Performance
Open $4.41 | Prev. Close N/A | Circuit Range N/A |
Day Range $4.41 - $4.41 | Year Range $0.14 - $15.75 | Volume 101 |
Average Traded $4.41 |
Ernexa Therapeutics Inc. Share Price Chart
$4.41$4.41
L
H
Ernexa Therapeutics Inc. Stock Fundamentals & Key Indicators
Market Cap $27.75M | PE Ratio (TTM) -1.96 | Dividend Yield N/A |
EPS (TTM) $-2.24 | Revenue (TTM) $582000.00 | Return On Equity (TTM) -586.59% |
Profit Margin -2419.93% | Debt to Equity 1.30 | Quarterly Earnings Growth YoY N/A |
Ernexa Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
Ernexa Therapeutics Inc. Annual Profit & Loss
All figures in USD
About Ernexa Therapeutics Inc.
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Ernexa Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $4.53 | $4.41 | -8.51% |
Aug 2026 | $3.42 | $4.82 | +41.76% |
Jul 2026 | $6.65 | $3.40 | -49.63% |
Jun 2026 | $9.44 | $6.75 | -35.84% |
May 2026 | $0.15 | $10.52 | +7,155.17% |
Apr 2026 | $0.21 | $0.14 | -27.86% |
Mar 2026 | $0.29 | $0.20 | -31.40% |
Feb 2026 | $1.25 | $0.29 | -75.98% |
Jan 2026 | $1.16 | $1.22 | +0.00% |
Dec 2025 | $1.28 | $1.22 | -9.63% |
Nov 2025 | $1.86 | $1.35 | -27.81% |
Oct 2025 | $1.25 | $1.87 | +59.15% |
ERNA Share Price FAQs
What is Ernexa Therapeutics Inc. share price today?
Ernexa Therapeutics Inc. share price today is $4.40 as on September 4, 2026 at 10:39 pm IST.
What is the 52 week high and 52 week low of Ernexa Therapeutics Inc. stock?
The 52 week high of Ernexa Therapeutics Inc. stock is $15.75, while the 52 week low is $0.14 as of 4 Sep '26.
What is ERNA's market capitalisation today?
ERNA market capitalisation is $27.75M as of September 7, 2026, at 11:44 pm IST.
What is ERNA's net income for the last quarter?
ERNA's net income for the last quarter is -0.03B USD.
What is the 5 year returns of ERNA?
The 5 year returns of ERNA is -99.84% as on 4 Sep '26.
What is the high & low stock price of ERNA today?
ERNA stock price hit a high of $4.41 and low of $4.41 as of 4 Sep '26.
Can I buy ERNA shares in India?
Yes. You can buy ERNA in India by opening an international trading account.